Methylprednisolone Completed Phase 2 Trials for Adverse Effect of Radiation Therapy / Brain Necrosis / Nasopharyngeal Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01621880Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma